Restructuring and Other Charges, Net

6 Months Ended

Jun. 30, 2022

Restructuring and Related Activities [Abstract]

Restructuring and Other Charges, Net

RESTRUCTURING AND OTHER CHARGES

Restructuring and other charges primarily consist of separation costs for employees including severance, outplacement and other employee benefit costs (“Severance”), charges related to the write-down of fixed assets of plants to be closed (“Fixed asset write-down”) and all other related restructuring (“Other”) costs. All restructuring and other charges are separately stated on the Consolidated Statements of Income (Loss) and Comprehensive (Loss) Income.

Frutarom Integration Initiative

In connection with the acquisition of Frutarom, the Company has been executing an integration plan that, among other initiatives, seeks to optimize its manufacturing network (the “Frutarom Integration Initiative”). As part of the Frutarom Integration Initiative, the Company now expects to close approximately 30 manufacturing sites with all closures targeted to occur by 2023. Since the inception of the initiative through June 30, 2022, the Company has closed 22 sites and expensed total costs of approximately $38 million. Total costs for the program are expected to be approximately $42 million including cash and non-cash items.

2019 Severance Program

During the year ended December 31, 2019, the Company incurred severance charges related to approximately 190 headcount reductions, excluding those previously mentioned under the Frutarom Integration Initiative. The headcount reductions primarily related to the Scent business unit with additional amounts related to headcount reductions in all business units associated with the establishment of a new shared service center in Europe. Since the inception of the program, the Company has expensed approximately $20 million to date.

N&B Merger Restructuring Liability

For the six months ended June 30, 2022, the Company incurred approximately $8 million of charges primarily related to severance. Since the inception of the restructuring activities, there have been approximately 270 headcount reductions and the Company has expensed approximately $38 million.

Changes in Restructuring Liabilities

Changes in restructuring liabilities during the six months ended June 30, 2022 were as follows:

(DOLLARS IN MILLIONS)	Balance at December 31, 2021		Additional Charges (Reversals), Net		Non-Cash Charges		Cash Payments		Balance at June 30, 2022
Frutarom Integration Initiative
Severance	$	5	$	—	$	—	$	—	$	5
Fixed asset write down	—		1		(1)		—		—
Other	3		—		—		(1)		2
2019 Severance Program
Severance	5		—		—		—		5
Other Restructuring Charges
Severance	1		—		—		—		1
N&B Merger Restructuring Liability
Severance	15		6		—		(8)		13
Other	—		2		—		(2)		—
Total restructuring and other charges	$	29	$	9	$	(1)	$	(11)	$	26

Restructuring liabilities are presented in “Other current liabilities” on the Consolidated Balance Sheets.

Charges by Segment

The following table summarizes the total amount of costs incurred in connection with these restructuring programs and activities by segment:

	Three Months Ended June 30,				Six Months Ended June 30,
(DOLLARS IN MILLIONS)	2022		2021		2022		2021
Nourish	$	1	$	17	$	3	$	20
Health & Biosciences	1		4		1		4
Scent	5		2		5		3
Pharma Solutions	—		1		—		1
Total Restructuring and other charges	$	7	$	24	$	9	$	28